Secur Credentials Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of SecUR Credentials Ltd is ₹ 1.63 as of 15 Apr 15:30 . The P/E Ratio of SecUR Credentials Ltd is 0 as of March 2021 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2021 . The Market Cap of SecUR Credentials Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2021 . The Dividend Payout of SecUR Credentials Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About SecUR Credentials Ltd

SecUR Credentials Limited was originally incorporated as a Private Limited Company with the name 'Axis Resources Private Limited' on 14th August, 2001.
Subsequently the name of the Company was changed to 'SecUR Credentials Private Limited' on July 18, 2016.
Further, it was converted into a Public Limited Company and the name of the Company was changed to 'SecUR Credentials Limited' on July 27, 2017. The Company is engaged in the business of Background Screening (also known as BGC - Background Check) and Due Diligence.
It is the end-to-end screening services provider to various corporates in the country.
The Company is one of the very few India-based BGC companies to be a member of the prestigious US-based National Association of Professional Background Screeners (NAPBS), APAC Chapter, which is the umbrella body of the largest BGC companies around the globe.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of SecUR Credentials Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, SecUR Credentials Ltd or Sheel Biotech Ltd?

Market cap of SecUR Credentials Ltd is 6 Cr while Market cap of Sheel Biotech Ltd is 110 Cr

What are the key factors driving the stock performance of SecUR Credentials Ltd and Sheel Biotech Ltd?

The stock performance of SecUR Credentials Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for SecUR Credentials Ltd and Sheel Biotech Ltd?

As of March 16, 2026, the SecUR Credentials Ltd stock price is INR ₹1.63. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.45.

How do dividend payouts of SecUR Credentials Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of SecUR Credentials Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.